SELECTED PUBLICATIONS

1. Fairchild and R. Bayer, “Changing Therapeutic Prospects and the Demise of Ethical Consensus on Unlinked Anonymous Testing for HIV in Developing Countries,” Public Health Reports, (In Press)

2. Fairchild and R. Bayer, “HIV Surveillance, Public Health and Clinical Medicine: Will the Walls Come Tumbling Down?” New England Journal of Medicine, (In Press).

3. R. Bayer, C. Edington, “HIV Testing, Human Rights, and Global AIDS Policy: Exceptionalism and Its Discontents,” Journal of Health Politics, Policy and Law 34(3) June 2009, 301-323.

4. G. Oppenheimer, R. Bayer, Shattered Dreams?: An Oral History of the South African AIDS Epidemic (Oxford University Press, 2007).

5. R. Bayer, A. Fairchild, “Changing the Paradigm for HIV Testing – The End of Exceptionalism,” New England Journal of Medicine 355 (7): August 2006, 647-649.

6. R. Bayer, “Ethical Challenges of HIV Vaccine Trials in Less Developed Nations: Conflict and Consensus in the International Arena,” AIDS 14 (8): May 2000, 1051-1057.

7. R. Bayer, A. Fairchild, “Surveillance and Privacy,” Science 290 (5498): December 2000, 1898-1899.

8. R. Bayer, J. Stryker, “Ethical Challenges Posed by Clinical Progress in AIDS,” American Journal of Public Health 87 (10): October 1997, 1599-1602. Reprinted in Contemporary Issues in Bioethics, 5th edition, Tom L. Beauchamp and LeRoy Walters, eds., (Belmont, CA: Wadsworth Publishing Company, 1999) 723-727.

9. R. Bayer, “Ethical Challenges Posed by Zidovudine Treatment to Reduce Vertical Transmission of HIV,” (editorial) New England Journal of Medicine 331 (18): November 1994, 1223-1225.

10. R. Bayer, “AIDS Prevention and Cultural Sensitivity: Are They Compatible?,” American Journal of Public Health 84 (6): June 1994, 895-898. Reprinted as “AIDS Prevention vs. Cultural Sensitivity,” in Responsive Community Winter 1995/1996, 20-27.

11. R. Bayer, “The Ethics of Blinded HIV Surveillance Testing,” American Journal of Public Health 83 (4): April 1993, 496-497.

12. R. Bayer, K. Toomey, “HIV Prevention and the Two Faces of Partner Notification,” American Journal of Public Health 82 (8): August 1992, 1158-1164.

13. R. Bayer, “Public Health Policy and the AIDS Epidemic: An End to HIV Exceptionalism?” New England Journal of Medicine 324 (21): May 1991, 1500-1504. Reprinted in Contemporary Issues in Bioethics, 4th edition, Tom L. Beauchamp and LeRoy Walters, eds., (Belmont, CA: Wadsworth Publishing Company, 1994) 534-539.

14. R. Bayer, “Perinatal Transmission of HIV Infection: The Ethics of Prevention,” Clinical Obstetrics and Gynecology 32 (3): September 1989, 497-505. Reprinted in a slightly revised form in Hospitals, Health Care Professionals and AIDS, ed. Lawrence O. Gostin, (Yale University Press, 1989).

15. R. Bayer, “AIDS and the Ethics of Public Health: Challenges Posed by a Maturing Epidemic,” AIDS 2 (Supplement 1): 1988, S217-S221.

16. R. Bayer, C. Levine, S. Wolf, “HIV Antibody Screening: An Ethical Framework for Evaluating Proposed Programs,” Journal of the American Medical Association 256 (13): October 1986, 1768-1774. Reprinted in Contemporary Issues in Bioethics, eds. Tom Beauchamp and LeRoy Walters (Wadsworth Publishing, 1988).

17. R. Bayer, C. Levine, T. Murray, “Guidelines for Confidentiality in Research on AIDS,” IRB 6 (6): November/December 1984, 1-7.

18. R. Bayer, “Gays and the Stigma of Bad Blood,” Hastings Center Report 13 (2): April 1983, 5-7.

<back to top>